Hélène Goulaouic

Sanofi (France) FR

0009-0003-4713-0216

Publications

2,172

Citations

H-Index

i10-Index

7.43

2yr Mean Cite

Cite/Paper

Data combined from OpenAlex . OA = OpenAlex S2 = Semantic Scholar

Verify on Google Scholar

Publication & Citation Trends

Most Cited Works

A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy

Baptiste Ronan, Odile Flamand, Lionel Vescovi, Christine Dureuil, Laurence Durand +12 more

Nature Chemical Biology 2014

484

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma OA

Michael E. Wechsler, Marcella Ruddy, Ian Pavord, Elliot Israel, Klaus F. Rabe +11 more

New England Journal of Medicine 2021

389

The Bloom's Syndrome Gene Product Interacts with Topoisomerase III OA

Leonard Wu, Sally L. Davies, Phillip North, Hélène Goulaouic, Jean‐François Riou +3 more

Journal of Biological Chemistry 2000

316

Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial

Klaus F. Rabe, Bartolomé R. Celli, Michael E. Wechsler, Raolat M. Abdulai, Xiaodong Luo +11 more

The Lancet Respiratory Medicine 2021

195

Directed integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase and Escherichia coli LexA protein OA

Hélène Goulaouic, S A Chow

Journal of Virology 1996

Publications

44 total

AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD PDF

Klaus F. Rabe, Fernando J. Martínez, Surya Prakash Bhatt, Tomotaka Kawayama, Borja G. Cosío et al. - ERJ Open Research, 2024

Cited by 29 OpenAlex

IL-33 Expression Is Lower in Current Smokers at both Transcriptomic and Protein Levels PDF

Alen Faiz, Rashad Mohammad Mahbub, Fia Boedijono, Milan I. Tomassen, Wierd Kooistra et al. - American Journal of Respiratory and Critical Care Medicine, 2023

Cited by 31 OpenAlex

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma PDF

Michael E. Wechsler, Marcella Ruddy, Ian Pavord, Elliot Israel, Klaus F. Rabe et al. - New England Journal of Medicine, 2021

Cited by 389 OpenAlex

Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial

Klaus F. Rabe, Bartolomé R. Celli, Michael E. Wechsler, Raolat M. Abdulai, Xiaodong Luo et al. - The Lancet Respiratory Medicine, 2021

Cited by 195 OpenAlex

A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy

Baptiste Ronan, Odile Flamand, Lionel Vescovi, Christine Dureuil, Laurence Durand et al. - Nature Chemical Biology, 2014

Cited by 484 OpenAlex

Discovery of (2S)-8-[(3R)-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2H-pyrimido[1,2-a]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors

Benoit Pasquier, Youssef El‐Ahmad, Bruno Filoche-Rommé, Christine Dureuil, Florence Fassy et al. - Journal of Medicinal Chemistry, 2014

Cited by 90 OpenAlex

Tricyclic Series of Heat Shock Protein 90 (Hsp90) Inhibitors Part I: Discovery of Tricyclic Imidazo[4,5-c]pyridines as Potent Inhibitors of the Hsp90 Molecular Chaperone PDF

François Vallée, Chantal Carrez, Fabienne Pilorge, A. Dupuy, Annick Parent et al. - Journal of Medicinal Chemistry, 2011

Cited by 46 OpenAlex

The Bloom's Syndrome Gene Product Interacts with Topoisomerase III PDF

Leonard Wu, Sally L. Davies, Phillip North, Hélène Goulaouic, Jean‐François Riou et al. - Journal of Biological Chemistry, 2000

Cited by 316 OpenAlex

Purification and characterization of human DNA topoisomerase IIIalpha PDF

Hélène Goulaouic - Nucleic Acids Research, 1999

Cited by 80 OpenAlex

Directed integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase and Escherichia coli LexA protein PDF

Hélène Goulaouic, S A Chow - Journal of Virology, 1996

Cited by 96 OpenAlex

Research Topics

Liver physiology and pathology (9) HIV Research and Treatment (8) HIV/AIDS drug development and treatment (8) Asthma and respiratory diseases (7) IL-33, ST2, and ILC Pathways (7)

Frequent Co-Authors

Sandrine Carteau

5 joint publications

Frédéric Subra

5 joint publications

Christian Auclair

5 joint publications

Raolat M. Abdulai

4 joint publications

Michael C. Nivens

4 joint publications

J.F. Mouscadet

4 joint publications

Affiliations

Southern Research Institute

US 2007 - 2007

Saint-Gobain (France)

FR 1999 - 1999

Centre National de la Recherche Scientifique

FR 1994 - 1993

Inserm

FR 1994 - 1993

UCLA Medical Center

US 1996 - 1996

External Profiles

OpenAlex Profile Search Semantic Scholar ORCID Profile Google Scholar

Share Profile

Back to Researchers

Hélène Goulaouic

Publication & Citation Trends

Most Cited Works

Publications

AERIFY-1/2: two phase 3, randomised, controlled trials of itepekimab in former smokers with moderate-to-severe COPD PDF

IL-33 Expression Is Lower in Current Smokers at both Transcriptomic and Protein Levels PDF

Efficacy and Safety of Itepekimab in Patients with Moderate-to-Severe Asthma PDF

Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial

A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy

Discovery of (2<i>S</i>)-8-[(3<i>R</i>)-3-Methylmorpholin-4-yl]-1-(3-methyl-2-oxobutyl)-2-(trifluoromethyl)-3,4-dihydro-2<i>H</i>-pyrimido[1,2-<i>a</i>]pyrimidin-6-one: A Novel Potent and Selective Inhibitor of Vps34 for the Treatment of Solid Tumors

Tricyclic Series of Heat Shock Protein 90 (Hsp90) Inhibitors Part I: Discovery of Tricyclic Imidazo[4,5-<i>c</i>]pyridines as Potent Inhibitors of the Hsp90 Molecular Chaperone PDF

The Bloom's Syndrome Gene Product Interacts with Topoisomerase III PDF

Purification and characterization of human DNA topoisomerase IIIalpha PDF

Directed integration of viral DNA mediated by fusion proteins consisting of human immunodeficiency virus type 1 integrase and Escherichia coli LexA protein PDF

Research Topics

Frequent Co-Authors

Affiliations

External Profiles

Share Profile

Hélène Goulaouic

Publication & Citation Trends

Most Cited Works

Publications

Research Topics

Frequent Co-Authors

Affiliations

External Profiles

Share Profile

Journal Details

Join JournalsHub

Welcome Back